A deli assistant with multiple sclerosis has won €4,000 in compensation after resigning from her part-time job when her manager could not guarantee her a reduction in working hours.

Dr Jiwon Oh looks forward to hearing updates on major clinical trials and long-term studies of new and emerging MS treatments at ECTRIMS 2025.

A North Hampshire woman is marking ten years since being diagnosed with multiple sclerosis (MS) by leading a 47-mile charity ...

Columnist Ben Hofmeister worries about his MS cognitive symptoms worsening and wonders if he'll even be aware of the changes.

AlterEgo's neural-interface device is non-invasive and is being tested in people with multiple sclerosis and amyotrophic ...

Drs Anne Cross and Scott Newsome discuss new horizons in MS treatment strategies, including the TREAT-MS trial and shared decision-making for optimal patient care.

An update from Contineum Therapeutics, Inc. Class A ( ($CTNM) ) is now available. On September 18, 2025, Contineum Therapeutics announced positive ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation ...

Those who prescribe larger amounts of MS drugs were more likely to have received payments, and those who got payments were ...

Yas Clinic- Khalifa city, and Abu Dhabi Stem Cells Center (ADSCC) have announced a pioneering collaboration that brings new, AI-supported MRI analys ...